Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard De La Garza

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Neuroscience and Biobehavioral Reviews|May 10, 2005
Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedoniaRichard De La Garza
Pharmacology, Biochemistry, and Behavior|October 18, 2005
Wistar Kyoto rats exhibit reduced sucrose pellet reinforcement behavior and intravenous nicotine self-administrationRichard De La Garza
Palliative & Supportive Care|August 16, 2018
Depressive, anxiety, and distress symptoms among cancer patients who endorse appearance problemsDeepti Chopra, Richard De La Garza
Brain Research|September 3, 2004
A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depressionRichard De La Garza, James J Mahoney
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2005
Interferon-induced depression: strategies in treatmentGregory M Asnis, Richard De La Garza
Brain Research|June 6, 2003
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampusRichard De La Garza, Gregory M Asnis
Journal of Clinical Gastroenterology|April 25, 2006
Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approachesGregory M Asnis, Richard De La Garza
Expert Opinion on Investigational Drugs|September 17, 2013
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medicationsChristopher D Verrico, Colin N Haile, Thomas F Newton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 29, 2020
Clinical relevance of a Body Image Scale cut point of 10 as an indicator of psychological distress in cancer patients: results from a psychiatric oncology clinicDeepti Chopra, Richard De La Garza, Tamara E Lacourt
Psychiatry Research|May 25, 2010
The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humansThomas F Newton, Richard De La Garza, Ken Grasing
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Neuroscience and Biobehavioral Reviews|May 10, 2005
Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedoniaRichard De La Garza
Pharmacology, Biochemistry, and Behavior|October 18, 2005
Wistar Kyoto rats exhibit reduced sucrose pellet reinforcement behavior and intravenous nicotine self-administrationRichard De La Garza
Palliative & Supportive Care|August 16, 2018
Depressive, anxiety, and distress symptoms among cancer patients who endorse appearance problemsDeepti Chopra, Richard De La Garza
Brain Research|September 3, 2004
A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depressionRichard De La Garza, James J Mahoney
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2005
Interferon-induced depression: strategies in treatmentGregory M Asnis, Richard De La Garza
Brain Research|June 6, 2003
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampusRichard De La Garza, Gregory M Asnis
Journal of Clinical Gastroenterology|April 25, 2006
Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approachesGregory M Asnis, Richard De La Garza
Expert Opinion on Investigational Drugs|September 17, 2013
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medicationsChristopher D Verrico, Colin N Haile, Thomas F Newton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 29, 2020
Clinical relevance of a Body Image Scale cut point of 10 as an indicator of psychological distress in cancer patients: results from a psychiatric oncology clinicDeepti Chopra, Richard De La Garza, Tamara E Lacourt
Psychiatry Research|May 25, 2010
The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humansThomas F Newton, Richard De La Garza, Ken Grasing
Pageof 11